Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 11:29 PM
Study NCT ID:
NCT00382993
Status:
COMPLETED
Last Update Posted:
2017-02-02
First Post:
2006-09-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2007-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-29
First Submit QC Date:
None
Study First Post Date:
2006-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2008-11-14
Results First Submit QC Date:
None
Results First Post Date:
2010-04-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-02
Last Update Post Date:
2017-02-02
Last Update Post Date Type:
ESTIMATED